Our Brand Story: Ultimaster™

Passion across three generations - engineers of Ultimaster™ talk about how we push the boundaries in developing each new generation of DES.
Passion across three generations - engineers of Ultimaster™ talk about how we push the boundaries in developing each new generation of DES.
Our Brand Story: Ultimaster™

Ultimaster Nagomi™

The latest generation of the Ultimaster™ DES family, bringing excellent deliverability, larger size line-up and an even greater over expansion capability.
The latest generation of the Ultimaster™ DES family, bringing excellent deliverability, larger size line-up and an even greater over expansion capability.
Ultimaster Nagomi™

MASTER DAPT

The MASTER DAPT study shows short DAPT to be noninferior to standard therapy of at least two months in terms of net and major adverse clinical events.
The MASTER DAPT study shows short DAPT to be noninferior to standard therapy of at least two months in terms of net and major adverse clinical events.
MASTER DAPT

Optimal DAPT duration

MASTER DAPT
interview with clinical expert.
MASTER DAPT
interview with clinical expert.
Learn from expert
Features
Clinical Evidence
Video Library
FAQ
Products
Ultimaster Nagomi
Ultimaster Tansei
Ultimaster
Topics
Our Brand Story: Utlimaster
Optimal DAPT Duration - Interview with Clinical Expert
MASTER DAPT
CCR (Complex Coronary Interventions through Radial)
Archive contents of Ultimaster™

Product Features

Infographic expressing Ultimaster™ product reliability (image)
Reliable BP-DES
BP-DES company with the most studies, longest history and one of the largest real world registry in the world1-4

Terumo is a pioneer of biodegradable polymer technology. Terumo launched world’s first BP-DES in 2008. Terumo has the longest history in manufacturing BP-DES. Ultimaster™ is the most studied BP-DES in the world with over 50,000 patients in this long history.1,2 e-Ultimaster which is the key clinical program covering various patient characteristics is one of the largest BP-DES registry in the world. e-Ultimaster proved good performance of Ultimaster™.3

Reliable BP-DES
Ultimaster™ product (image)
Designed by a TRI pioneer
Smooth deliverability

Ultimaster™ is designed by Terumo, a TRI pioneer. Ultimaster™’s delivery catheter is designed for TRI aimed at facilitating procedures done under an unstable back-up condition. The advanced shaft technology, flexible stent design and innovative tip provide less stressful treatment for you and your patients even in challenging complex lesions.

Designed by a TRI pioneer
Ultimaster™ stent in bifurcation blood vessel (image)
Bifurcation excellence
Designed to facilitate bifurcation

Ultimaster™ stent has a uniform open-cell platform. Ultimaster™ facilitates procedures in bifurcation lesions with its wider over-expansion capability, smooth side-branch access and reliable drug delivery.

Bifurcation excellence

Reference

 
  1. Comparison result with Biomatrix(Biosensors), Orsiro(biotronik) and Synergy(Boston scientific) based on information from only press release or product website at April 2020.

  2. Total studied patient including Terumo sponsored trials and initiated research at April 2020.

  3. M. Roffi, Insight in real-world PCI practice and clinical outcomes of patients treated with a new-generation DES presented at EuroPCR2019.

  4. Based on CE mark approval date, Nobori was approved on January 16th, 2008.

Features
Clinical Evidence
Video Library
FAQ
Related Contents

Products

Recommendation

Our Brand Story - Terumo associates share their stories, exploring challenges faced in their careers and how they overcame them.
Therapeutic Lesion Access (Cardiology) - We support successful PCI procedures with a range of high-quality and reliable therapeutic lesion access devices.
HeartrailII - A guiding catheter that aims to support safe and efficient procedures